DUK
52
-5
VZ
35
-2
PYPL
52
2
STT
62
3
PGR
42
2
AEE
51
-7
LNC
75
2
WFC
74
5
IVZ
70
2
OI
47
-11
KLAC
72
2
INTU
60
-3
APA
53
5
ZTS
21
2
EFX
54
2
CME
45
3
GS
76
6
ADM
47
2
FDX
74
3
EW
58
5
DUK
52
-5
VZ
35
-2
PYPL
52
2
STT
62
3
PGR
42
2
AEE
51
-7
LNC
75
2
WFC
74
5
IVZ
70
2
OI
47
-11
KLAC
72
2
INTU
60
-3
APA
53
5
ZTS
21
2
EFX
54
2
CME
45
3
GS
76
6
ADM
47
2
FDX
74
3
EW
58
5
Financhill
Back

Monte Rosa Therapeutics, Inc. Vs. Nebius Group NV Industry Stock Comparison

Sell
48

GLUE
Monte Rosa Therapeutics, Inc.

Last Price:
$15.47
Seasonality Move:
-6.15%
Sell
42

NBIS
Nebius Group NV

Last Price:
$89.47
Seasonality Move:
-2.57%
Sell
48
Monte Rosa Therapeutics, Inc. (GLUE) is a Sell

Is Monte Rosa Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monte Rosa Therapeutics, Inc. [GLUE] share price is $15.54. The Score for GLUE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • GLUE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy, Sell or Hold?

  • The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GLUE Stock Price Chart

What is Monte Rosa Therapeutics, Inc.'s stock price today?

  • The Monte Rosa Therapeutics, Inc. share price today is $15.54
    The current trend is moderately bearish and GLUE is experiencing selling pressure, which indicates risk of future bearish movement.

NBIS Stock Price Chart

What is Nebius Group NV's stock price today?

  • The Nebius Group NV share price today is $89.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

GLUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 49.68 Sell
Chaikin Money Flow: -2524399 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.6 - 17.28) Sell
Bollinger Bands (100): (5.14 - 14.32) Buy

NBIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.05 Sell
Relative Strength Index (14 RSI): 47.32 Sell
Chaikin Money Flow: 13904832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.34 - 98.02) Sell
Bollinger Bands (100): (72.32 - 115.66) Sell

GLUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.67 Sell
20-day SMA: 16.45 Sell
50-day SMA: 13.86 Buy
200-day SMA: 7.33 Buy
8-day EMA: 16.48 Sell
20-day EMA: 16.08 Sell
50-day EMA: 13.89 Buy
200-day EMA: 8.96 Buy

NBIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.08 Buy
20-day SMA: 91.37 Sell
50-day SMA: 102.98 Sell
200-day SMA: 65.21 Buy
8-day EMA: 85.42 Buy
20-day EMA: 90.53 Sell
50-day EMA: 95.55 Sell
200-day EMA: 73.6 Buy

Monte Rosa Therapeutics, Inc. Earnings Growth & GLUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $1.12 per share.

Nebius Group NV Earnings Growth & NBIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.

Monte Rosa Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nebius Group NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):